- PR Newswire•3 days agoJohnson & Weaver, LLP Announces Investigations of Clovis Oncology, Inc., USANA Health Sciences, Inc., Anthera Pharmaceuticals, Inc., and PixarBio Corporation
Johnson & Weaver, LLP is investigating potential violations of federal and state securities laws by Clovis Oncology, Inc. (CLVS) and certain of its officers. On November 19, 2015, a class action lawsuit was filed against Clovis over alleged securities laws violations.
- Investor's Business Daily•4 days ago
Pfizer and Tesaro could follow AstraZeneca which, early Friday, unveiled strong results from a trial of Lynparza in breast cancer.
- TheStreet.com•4 days ago
AstraZeneca shares, meanwhile, were less-than-moved by the news.
CLVS : Summary for Clovis Oncology, Inc. - Yahoo Finance
Clovis Oncology, Inc. (CLVS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||63.48 x 200|
|Ask||63.49 x 500|
|Day's Range||63.25 - 65.59|
|52 Week Range||11.57 - 67.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-6.12|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|